HKU Scholars Hub: Browsing DSpace

Browsing by Author Bruix, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 4 of 4

	Title	Author(s)	Issue Date	Views
	Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial Journal:The Lancet Oncology	Bruix, J Takayama, T Mazzaferro, V Chau, GY Yang, J Kudo, M Cai, J Poon, RTP Han, KH Tak, WY Lee, HC Song, T Roayaie, S Bolondi, L Lee, KS Makuuchi, M Souza, F Berre, MA Meinhardt, G Llovet, JM	2015	118
	Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma Journal:Journal of Hepatology	Finn, RS Poon, RTP Yau, TCC Klümpen, HJ Chen, LT Kang, YK Kim, TY Gomez-Martin, C Rodriguez-Lope, C Kunz, T Paquet, T Brandt, U Sellami, D Bruix, J	2013	70
	Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) Proceeding/Conference:Journal of Clinical Oncology	Finn, RS Poon, RTP Yau, T Klumpen, H Chen, L Kang, Y Kim, T Gomez-Martin, C Rodriguez-Lope, C Kunz, T Paquet, T Asubonteng, K Winkler, RE Anak, O Sellami, DB Bruix, J	2011	146
	Safety, efficacy, and pharmacodynamics of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma: Randomized expansion of a phase I/II study Journal:Journal of Clinical Oncology	Kelley, RK Sangro, B Harris, W Ikeda, M Okusaka, T Kang, YK Qin, S Tai, DWM Lim, HY Yau, T Yong, WP Cheng, AL Gasbarrini, A Damian, S Bruix, J Borad, M Bendell, J Kim, TY Standifer, N He, P Makowsky, M Negro, A Kudo, M Abou-Alfa, GK	2021	23

Showing results 1 to 4 of 4